Gilead Sciences CEO Daniel Patrick O'Day reports sale of $5.33 million in common shares
GILD•Gilead Sciences Chairman and CEO Daniel Patrick O'Day sold 30,881 common shares on Oct. 30 and Nov. 2, 2026. His directly owned holdings stood at 551,683 shares after the transactions.
1. Share sales and options
O'Day sold 15,881 shares on Oct. 30 at $175.2456 per share and 15,000 shares on Nov. 2 at prices ranging from $167.3999 to $171.0627. On Oct. 30, he also exercised 15,881 non-qualified stock options at $72.34 per share.
